Michael E. Wechsler, MD, MMSc, Professor of Medicine at National Jewish Health and University of Colorado School of Medicine talks about the need for clinicians to be more aware about  Eosinophilic granulomatosis with polyangiitis (EGPA). This rare autoimmune disease, previously referred to as Churg Strauss syndrome, is a type of primary systemic autoimmune vasculitis characterized by inflammation of blood vessels.

EGPA affects about 5,000 people in the United States and as such, most clinicians are likely not familiar with this rare disease. Treatment options are available for persons with EGPA, so it is imperative that health care professionals be aware of how to recognize, and/or suspect, this condition.

CheckRare’s continuing education program about EGPA is a four-module program developed by Dr. Wechsler to educate health professionals about the pathophysiology, symptoms, diagnostic challenges, and treatment options for EGPA. 

CME credited modules include: